Congenital disorders of glycosylation

Congenital (genetic) disorders of glycosylation (CDG) are a rapidly growing disease family, with some 45 members reported since its first clinical description in 1980. Most of these are protein hypoglycosylation diseases, but recently three defects in lipid glycosylation have been identified. Most protein hypoglycosylation diseases are due to defects in the N‐glycosylation pathway (16 diseases). The remaining ones affect the O‐glycosylation pathway (8 diseases), both the N‐ and the O‐glycosylation pathways, or other pathways (17 diseases). CDG can affect nearly all organs and systems, but there is often an important neurological component. The first‐line screening for the N‐glycosylation diseases is serum transferrin isoelectrofocusing (IEF), and for the O‐glycosylation disorders apo CIII IEF. It has to be stressed that a normal test result does by no means exclude a CDG. In case of an abnormal result and as long as the basic defect has not been elucidated, the disease is labeled CDG‐x (CDG‐Ix when the transferrin IEF shows a type 1 pattern, and CDG‐IIx when it shows a type 2 pattern).

[1]  B. Hagberg,et al.  Carbohydrate-deficient glycoprotein syndrome: clinical expression in adults with a new metabolic disease. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[2]  M. Nöthen,et al.  Localization of the human glucosidase I gene to chromosome 2p12-p13 by fluorescence in situ hybridization and PCR analysis of somatic cell hybrids. , 1996, Genomics.

[3]  T. Marquardt,et al.  Carbohydrate-deficient glycoprotein syndrome (CDGS)--glycosylation, folding and intracellular transport of newly synthesized glycoproteins. , 1995, European journal of cell biology.

[4]  M. Irving,et al.  The skeletal manifestations of the congenital disorders of glycosylation , 2008, Clinical genetics.

[5]  J. Jaeken,et al.  Diagnosis of congenital disorders of glycosylation by capillary zone electrophoresis of serum transferrin. , 2004, Clinical chemistry.

[6]  A. Cleton-Jansen,et al.  EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. , 1999, American journal of human genetics.

[7]  H. Freeze,et al.  Failure of short‐term mannose therapy of patients with carbohydrate‐deficient glycoprotein syndrome type 1A , 1998, Acta paediatrica.

[8]  H. Freeze,et al.  CDG‐Id in two siblings with partially different phenotypes , 2007, American journal of medical genetics. Part A.

[9]  J. Jaeken,et al.  Congenital disorders of glycosylation: a booming chapter of pediatrics. , 2004, Current opinion in pediatrics.

[10]  G. Turcatti,et al.  Purification, cDNA cloning and heterologous expression of human phosphomannose isomerase. , 1994, European journal of biochemistry.

[11]  Y. Wada,et al.  Oligosaccharide structures of immunoglobulin G from two patients with carbohydrate-deficient glycoprotein syndrome , 1994 .

[12]  H. Kayserili,et al.  Identification of loss-of-function mutations of SLC35D1 in patients with Schneckenbecken dysplasia, but not with other severe spondylodysplastic dysplasias group diseases , 2009, Journal of Medical Genetics.

[13]  M. Schwartz,et al.  Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia) , 2000, European Journal of Human Genetics.

[14]  G. Matthijs,et al.  Annals of the New York Academy of Sciences Congenital Disorders of Glycosylation , 2022 .

[15]  J. Jaeken,et al.  The carbohydrate-deficient glycoprotein syndrome. A new inherited multisystemic disease with severe nervous system involvement. , 1991, Acta paediatrica Scandinavica. Supplement.

[16]  R. Wevers,et al.  Clinical and biochemical presentation of siblings with COG-7 deficiency, a lethal multiple O- and N-glycosylation disorder , 2005, Journal of Inherited Metabolic Disease.

[17]  Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency. , 2007 .

[18]  M. Besnard,et al.  Diagnostic value of Western blotting in carbohydrate-deficient glycoprotein syndrome. , 1996, Clinica chimica acta; international journal of clinical chemistry.

[19]  S. Povey,et al.  Chromosome assignment of some human enzyme loci: mitochondrial malate dehydrogenase to 7, mannosephosphate isomerase and pyruvate kinase to 15 and probably, esterase D to 13 , 1975, Annals of human genetics.

[20]  G. Raymond,et al.  MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. , 2001, The Journal of clinical investigation.

[21]  J. Jaeken,et al.  A Newly Recognized Inherited Neurological Disease with Carbohydrate Deficient Secretory Glycoproteins , 1989 .

[22]  M. Carrozzi,et al.  Carbohydrate-deficient glycoprotein syndromes: The Italian experience , 2000, Journal of Inherited Metabolic Disease.

[23]  H. Freeze,et al.  Human Fibroblasts Prefer Mannose over Glucose as a Source of Mannose for N-Glycosylation , 1997, The Journal of Biological Chemistry.

[24]  N. Perrimon,et al.  Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion , 1998, Nature.

[25]  E. Schaftingen,et al.  Defects of N-glycan synthesis , 2001 .

[26]  Kazuro Furukawa,et al.  Molecular Basis for the Progeroid Variant of Ehlers-Danlos Syndrome , 1999, The Journal of Biological Chemistry.

[27]  H. Freeze,et al.  Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG‐Ia) , 2000, Human mutation.

[28]  T. Hennet,et al.  Congenital disorders of glycosylation: genetic model systems lead the way. , 2001, Trends in cell biology.

[29]  C. Zweier,et al.  New Mutations of EXT1 and EXT2 Genes in German Patients with Multiple Osteochondromas , 2009, Annals of human genetics.

[30]  O. Bohorov,et al.  Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder , 2004, Nature Medicine.

[31]  F. Hanefeld,et al.  Carbohydrate-deficient glycoprotein syndrome type V: deficiency of dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Berger,et al.  A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide. , 1998, The Journal of clinical investigation.

[33]  Susan C. Brown,et al.  Defective glycosylation in muscular dystrophy , 2002, The Lancet.

[34]  U. Pannicke,et al.  Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II , 2009, Nature Genetics.

[35]  J. Marth,et al.  Immune regulation by the ST6Gal sialyltransferase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Freeze,et al.  Mannose Enters Mammalian Cells Using a Specific Transporter That Is Insensitive to Glucose (*) , 1996, The Journal of Biological Chemistry.

[37]  Gert Matthijs,et al.  Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic , 2000, Human Genetics.

[38]  H. Freeze,et al.  Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie) , 2000, The Journal of clinical investigation.

[39]  J. Jaeken,et al.  Congenital disorders of glycosylation (CDG): It's all in it! , 2003, Journal of Inherited Metabolic Disease.

[40]  A. Dell,et al.  The carbohydrate-deficient glycoprotein syndrome: an experiment of nature in glycosylation. , 1995, Biochemical Society transactions.

[41]  J. Denecke,et al.  Hypoglycosylation due to dolichol metabolism defects. , 2009, Biochimica et biophysica acta.

[42]  C. McCormick,et al.  The Putative Tumor Suppressors EXT1 and EXT2 Are Glycosyltransferases Required for the Biosynthesis of Heparan Sulfate* , 1998, The Journal of Biological Chemistry.

[43]  M. Schwartz,et al.  Absence of homozygosity for predominant mutations in PMM2 in Danish patients with carbohydrate-deficient glycoprotein syndrome type 1 , 1998, European Journal of Human Genetics.

[44]  P. Stanley,et al.  Glycosyltransferase mutants: key to new insights in glycobiology , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  U. Stephani,et al.  Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl‐P‐Man:Man5 GlcNAc2‐PP‐dolichyl mannosyltransferase , 1999, The EMBO journal.

[46]  H. Freeze Human disorders in N-glycosylation and animal models. , 2002, Biochimica et biophysica acta.

[47]  E. Schaftingen,et al.  Carbohydrate-deficient glycoprotein syndrome: Beyond the screen , 2000, Journal of Inherited Metabolic Disease.

[48]  Sebastian Bauer,et al.  Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome , 2010, Nature Genetics.

[49]  J. Saudubray,et al.  Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose. , 1999, The Journal of pediatrics.

[50]  J. Jaeken,et al.  Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development. , 1996, American journal of human genetics.

[51]  K. Takeshita,et al.  Hemostatic studies in patients with carbohydrate-deficient glycoprotein syndrome. , 1994, Thrombosis research.

[52]  M. Lovett,et al.  The structure of the human multiple exostoses 2 gene and characterization of homologs in mouse and Caenorhabditis elegans. , 1997, Genome research.

[53]  W. Annaert,et al.  Cerebrocostomandibular-like syndrome and a mutation in the conserved oligomeric Golgi complex, subunit 1. , 2008, Human molecular genetics.

[54]  Y. Iwakura,et al.  Growth retardation and early death of β‐1, 4‐galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells , 1997, The EMBO journal.

[55]  P. Clayton,et al.  Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1 , 2000, Journal of Inherited Metabolic Disease.

[56]  Y. Maeda,et al.  Targeted therapy for inherited GPI deficiency. , 2007, The New England journal of medicine.

[57]  Gert Matthijs,et al.  Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2 , 2008, Nature Genetics.

[58]  E. Schaftingen,et al.  High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency). , 2001, American journal of human genetics.

[59]  E. Schaftingen,et al.  Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A. , 1998, American journal of human genetics.

[60]  P. de Cock,et al.  Carbohydrate-deficient glycoprotein syndrome type II , 1993, Journal of Inherited Metabolic Disease.

[61]  D. A. Spencer,et al.  Carbohydrate deficient glycoprotein syndrome; multiple abnormalities and diagnostic delay. , 1995, Archives of disease in childhood.

[62]  L. Sturla,et al.  Impairment of the Golgi GDP-l-Fucose Transport and Unresponsiveness to Fucose Replacement Therapy in LAD II Patients , 2001, Pediatric Research.

[63]  J. Jaeken,et al.  Developmental patterns and neuropsychological assessment in patients with carbohydrate-deficient glycoconjugate syndrome type IA (phosphomannomutase deficiency) , 1999, Brain and Development.

[64]  M. Wagner,et al.  Genomic organization and promoter structure of the human EXT1 gene. , 1997, Genomics.

[65]  Gert Matthijs,et al.  A novel mutation and first report of dilated cardiomyopathy in ALG6-CDG (CDG-Ic): a case report , 2010, Orphanet journal of rare diseases.

[66]  J. Jaeken,et al.  Defective glycosyltransferases are not good for your health. , 1998, Advances in experimental medicine and biology.

[67]  J. Jaeken,et al.  Lysosomal enzyme activities in serum and leukocytes from patients with carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase deficiency) , 1998, Journal of Inherited Metabolic Disease.

[68]  R. Wevers,et al.  Vacuolar H+-ATPase meets glycosylation in patients with cutis laxa. , 2009, Biochimica et biophysica acta.

[69]  B. Winchester,et al.  Modification of Glycosylation as A Therapeutic Strategy , 2000 .

[70]  Andrés Hidalgo,et al.  Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene. , 2003, Blood.

[71]  D. Rimoin,et al.  Nucleotide-sugar transporter SLC35D1 is critical to chondroitin sulfate synthesis in cartilage and skeletal development in mouse and human , 2007, Nature Medicine.

[72]  H. Freeze,et al.  Clinical and molecular characterization of the first adult congenital disorder of glycosylation (CDG) type Ic patient , 2005, American journal of medical genetics. Part A.

[73]  F. Hanefeld,et al.  Carbohydrate-Deficient Glycoprotein (CDG) Syndrome - A New Variant, Type III , 1993, Neuropediatrics.

[74]  C. Walsh,et al.  Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. , 2002, American journal of human genetics.

[75]  J. Gécz,et al.  Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. , 2008, American journal of human genetics.

[76]  M. Bayés,et al.  Clinical and genetic distinction between Walker–Warburg syndrome and muscle–eye–brain disease , 2001, Neurology.

[77]  F. Foulquier COG defects, birth and rise! , 2009, Biochimica et biophysica acta.

[78]  E. Berger,et al.  Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. , 2000, The Journal of clinical investigation.

[79]  J. Collet,et al.  A New Class of Phosphotransferases Phosphorylated on an Aspartate Residue in an Amino-terminal DXDX(T/V) Motif* , 1998, The Journal of Biological Chemistry.

[80]  H. Freeze,et al.  Analysis of multiple mutations in the hALG6 gene in a patient with congenital disorder of glycosylation Ic. , 2000, Molecular genetics and metabolism.

[81]  G. Matthijs,et al.  The prenatal diagnosis of congenital disorders of glycosylation (CDG) , 2004, Prenatal diagnosis.

[82]  A. Zanella,et al.  Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene , 2009, Human mutation.

[83]  H. Freeze,et al.  Correction of leukocyte adhesion deficiency type II with oral fucose. , 1999, Blood.

[84]  J. Jaeken,et al.  Familial psychomotor retardation with markedly fluctuating serum prolactin, FSH and GH levels, partial TBG-deficiency, increased serum arylsulphatase A and increased CSF protein: a new syndrome?: 90 , 1980, Pediatric Research.

[85]  K. Takeshita,et al.  The carbohydrate deficient glycoprotein syndrome in three Japanese children , 1992, Brain and Development.

[86]  J. Tissot,et al.  Microheterogeneity of serum glycoproteins and their liver precursors in patients with carbohydrate-deficient glycoprotein syndrome type I: apparent deficiencies in clusterin and serum amyloid P. , 1997, The Journal of laboratory and clinical medicine.

[87]  K. Yamashita,et al.  Electrospray ionization-mass spectrometric analysis of serum transferrin isoforms in patients with carbohydrate-deficient glycoprotein syndrome. , 1993, Journal of biochemistry.

[88]  P. de Cock,et al.  MGAT2 deficiency (CDG-IIa): the Life of J. , 2009, Biochimica et biophysica acta.

[89]  A Etzioni,et al.  Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. , 1992, The New England journal of medicine.

[90]  Gert Matthijs,et al.  Congenital disorders of glycosylation: a rapidly expanding disease family. , 2007, Annual review of genomics and human genetics.

[91]  M. Durán,et al.  A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. , 1998, Biochemical and biophysical research communications.

[92]  T. Hennet,et al.  On the nomenclature of congenital disorders of glycosylation (CDG) , 2008, Journal of Inherited Metabolic Disease.

[93]  E. Berger,et al.  Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL. , 2004, American journal of human genetics.

[94]  Gert Matthijs,et al.  Deficiencies in subunits of the Conserved Oligomeric Golgi (COG) complex define a novel group of Congenital Disorders of Glycosylation. , 2008, Molecular genetics and metabolism.

[95]  H. Freeze,et al.  Mannose corrects altered N-glycosylation in carbohydrate-deficient glycoprotein syndrome fibroblasts. , 1996, The Journal of clinical investigation.

[96]  J. Jaeken,et al.  The carbohydrate-deficient glycoprotein syndromes: pre-Golgi and Golgi disorders? , 1993, Glycobiology.

[97]  J. Denecke,et al.  Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies , 2003, European Journal of Pediatrics.

[98]  J. Jaeken,et al.  Carbohydrate-deficient glycoconjugate (CDG) syndromes: a new chapter of neuropaediatrics. , 1997, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[99]  C. Nordborg,et al.  Sural Nerve Pathology in the Carbohydrate‐deficient Glycoprotein Syndrome , 1991 .

[100]  N. Galeano,et al.  Secretory diarrhea with protein-losing enteropathy, enterocolitis cystica superficialis, intestinal lymphangiectasia, and congenital hepatic fibrosis: a new syndrome. , 1986, The Journal of pediatrics.

[101]  M. Wagner,et al.  Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1) , 1995, Nature Genetics.

[102]  J. Denecke,et al.  A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy. , 2007, American journal of human genetics.

[103]  D. Dunger,et al.  Familial olivopontocerebellar atrophy with neonatal onset: a recessively inherited syndrome with systemic and biochemical abnormalities. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[104]  H. Freeze,et al.  SRD5A3 Is Required for Converting Polyprenol to Dolichol and Is Mutated in a Congenital Glycosylation Disorder , 2010, Cell.

[105]  H. Freeze,et al.  Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. , 1998, The Journal of clinical investigation.

[106]  M. Acarregui,et al.  Carbohydrate-deficient glycoprotein syndrome type 1 with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities. , 1998, The Journal of pediatrics.

[107]  D. Sillence,et al.  Mutation of the LUNATIC FRINGE gene in humans causes spondylocostal dysostosis with a severe vertebral phenotype. , 2006, American journal of human genetics.

[108]  J. Jaeken,et al.  Hypoglycosylation of a brain glycoprotein (beta-trace protein) in CDG syndromes due to phosphomannomutase deficiency and N-acetylglucosaminyl-transferase II deficiency. , 1997, Glycobiology.

[109]  M. Burch,et al.  Cardiomyopathy in the congenital disorders of glycosylation (CDG): a case of late presentation and literature review , 2009, Journal of Inherited Metabolic Disease.

[110]  J. Denecke,et al.  Congenital dyserythropoietic anemia type II (CDAII/HEMPAS): where are we now? , 2009, Biochimica et biophysica acta.

[111]  E. Berger,et al.  A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[112]  E. Morava,et al.  CDG – an update , 2011, Journal of Inherited Metabolic Disease.

[113]  M. Mäki,et al.  Peters’-plus syndrome is a congenital disorder of glycosylation caused by a defect in the β1,3-glucosyltransferase that modifies thrombospondin type 1 repeats , 2009, Annals of medicine.

[114]  C. Rodeck,et al.  Carbohydrate-deficient glycoprotein syndrome: normal glycosylation in the fetus , 1993, The Lancet.

[115]  J. L. Potter,et al.  Lipoprotein disorder, cirrhosis, and olivopontocerebellar degeneration in two siblings , 1986, Neurology.

[116]  Hudson H. Freeze,et al.  Genetic defects in the human glycome , 2006, Nature Reviews Genetics.

[117]  M. Mizuno,et al.  Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. , 2001, Developmental cell.

[118]  J. Hewitt Abnormal glycosylation of dystroglycan in human genetic disease. , 2009, Biochimica et biophysica acta.

[119]  P. Clayton,et al.  Carbohydrate-Deficient Glycoprotein Syndromes: Inborn Errors of Protein Glycosylation , 1999, Annals of clinical biochemistry.

[120]  W. Wuyts,et al.  Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes , 2000, Human Mutation.

[121]  S. Nilsson,et al.  PMM2 mutation spectrum, including 10 novel mutations, in a large CDG type 1A family material with a focus on Scandinavian families , 2000, Human mutation.

[122]  E. Schaftingen,et al.  Prenatal diagnosis in CDG1 families: beware of heterogeneity , 1998, European Journal of Human Genetics.

[123]  J. Jaeken,et al.  Biochemical Characteristics and Diagnosis of the Carbohydrate‐deficient Glycoprotein Syndrome , 1991 .

[124]  V. Ramaekers,et al.  A new variant of the carbohydrate deficient glycoproteins syndrome , 1991, Journal of Inherited Metabolic Disease.

[125]  N. Conradi,et al.  The heart and pericardial effusions in CDGS-I (carbohydrate-deficient glycoprotein syndrome type I) , 1998, Journal of Inherited Metabolic Disease.

[126]  H. G. Eijk,et al.  Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome. , 1984, Clinica chimica acta; international journal of clinical chemistry.

[127]  M. Aebi,et al.  The dolichol pathway of N-linked glycosylation. , 1999, Biochimica et biophysica acta.

[128]  Y. Wada,et al.  Structure of serum transferrin in carbohydrate-deficient glycoprotein syndrome. , 1992, Biochemical and biophysical research communications.

[129]  R. Pauli,et al.  Natural history study of hereditary multiple exostoses. , 1995, American journal of medical genetics.

[130]  M. Budarf,et al.  PMM (PMM1), the human homologue of SEC53 or yeast phosphomannomutase, is localized on chromosome 22q13. , 1997, Genomics.

[131]  Gert Matthijs,et al.  CDG nomenclature: time for a change! , 2009, Biochimica et biophysica acta.

[132]  M. Knaap,et al.  Congenital nephrotic syndrome: A novel phenotype of type I carbohydrate-deficient glycoprotein syndrome , 1996, Journal of Inherited Metabolic Disease.

[133]  A. Varki,et al.  Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.

[134]  S. Kornfeld,et al.  Assembly of asparagine-linked oligosaccharides. , 1985, Annual review of biochemistry.

[135]  F. Hanefeld,et al.  Congenital disorder of glycosylation-Ic: case report and genetic defect. , 2000, Neuropediatrics.

[136]  J. Marth,et al.  A genetic approach to Mammalian glycan function. , 2003, Annual review of biochemistry.

[137]  J. Squire,et al.  The human UDP-N-acetylglucosamine: alpha-6-D-mannoside-beta-1,2- N-acetylglucosaminyltransferase II gene (MGAT2). Cloning of genomic DNA, localization to chromosome 14q21, expression in insect cells and purification of the recombinant protein. , 1995, European journal of biochemistry.

[138]  E. Quentin,et al.  A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[139]  P. de Cock,et al.  Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II. , 1994, Archives of disease in childhood.

[140]  D. Vestweber,et al.  Leukocyte Adhesion Deficiency II: Therapy and Genetic Defect , 2002, Cells Tissues Organs.

[141]  G. Matthijs,et al.  Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia). , 1999, Molecular genetics and metabolism.

[142]  E. Schaftingen,et al.  Phosphomannomutase deficiency is the main cause of carbohydrate-deficient glycoprotein syndrome with type I isoelectrofocusing pattern of serum sialotransferrins , 1997, Journal of Inherited Metabolic Disease.

[143]  G. Matthijs,et al.  Evidence for genetic heterogeneity in the carbohydrate-deficient glycoprotein syndrome type I (CDG1). , 1996, Genomics.

[144]  M. Lovett,et al.  The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes , 1996, Nature Genetics.

[145]  K. von Figura,et al.  Carbohydrate-deficient glycoprotein syndrome type 1: correction of the glycosylation defect by deprivation of glucose or supplementation of mannose , 1998, Glycoconjugate Journal.

[146]  T. Hennet,et al.  RFT1-CDG: Deafness as a novel feature of congenital disorders of glycosylation , 2009, Journal of Inherited Metabolic Disease.

[147]  I. Tygstrup,et al.  CONGENITAL HEPATIC FIBROSIS COMBINED WITH PROTEIN‐LOSING ENTEROPATHY AND RECURRENT THROMBOSIS , 1980, Acta paediatrica Scandinavica.

[148]  B. D. de Vries,et al.  Positional cloning of a gene involved in hereditary multiple exostoses. , 1996, Human molecular genetics.

[149]  J. Jaeken,et al.  Clinical Presentation and Natural Course of the Carbohydrate‐deficient Glycoprotein Syndrome , 1991 .

[150]  P. Codogno,et al.  Alteration of mannose transport in fibroblasts from type I carbohydrate deficient glycoprotein syndrome patients. , 1999, Biochimica et biophysica acta.

[151]  W. Schima,et al.  Budd-Chiari syndrome associated with coagulation abnormalities in a child with carbohydrate deficient glycoprotein syndrome type Ix. , 2000, The Journal of pediatrics.

[152]  S. Dunwoodie The role of Notch in patterning the human vertebral column. , 2009, Current Opinion in Genetics and Development.

[153]  E. Bieberich,et al.  Cloning and expression of glucosidase I from human hippocampus. , 1995, European journal of biochemistry.

[154]  E. Pardon,et al.  Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13 in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome) , 1997, Nature Genetics.

[155]  C. Thiel,et al.  Fatal outcome due to deficiency of subunit 6 of the conserved oligomeric Golgi complex leading to a new type of congenital disorders of glycosylation. , 2010, Human molecular genetics.

[156]  K. von Figura,et al.  Deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik. , 2004, American journal of human genetics.

[157]  E. Bertini,et al.  Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. , 1998, American journal of human genetics.

[158]  L. Wide,et al.  Gonadal function and glycoprotein hormones in the carbohydrate‐deficient glycoprotein (CDG) syndrome , 1995, Acta paediatrica.

[159]  F. Hanefeld,et al.  Linkage of a locus for carbohydrate-deficient glycoprotein syndrome type I (CDG1) to chromosome 16p, and linkage disequilibrium to microsatellite marker D16S406. , 1994, Human molecular genetics.

[160]  C. McCormick,et al.  The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[161]  G. Matthijs,et al.  Detailed mapping of the phosphomannomutase 2 (PMM2) gene and mutation detection enable improved analysis for Scandinavian CDG type I families , 1998, European Journal of Human Genetics.

[162]  E. Sprecher,et al.  Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis. , 2009, Biochimica et biophysica acta.

[163]  I. Casteels,et al.  Evolution of ophthalmic and electrophysiological findings in identical twin sisters with the carbohydrate deficient glycoprotein syndrome type 1 over a period of 14 years. , 1996, British Journal of Ophthalmology.

[164]  J. Jaeken,et al.  What's new in congenital disorders of glycosylation? , 2000, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[165]  F. Skovby,et al.  Fine mapping of the gene for carbohydrate-deficient glycoprotein syndrome, type I (CDG1): linkage disequilibrium and founder effect in Scandinavian families. , 1997, Genomics.

[166]  H. Freeze,et al.  Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome. , 1999, The Journal of pediatrics.

[167]  P. de Lonlay,et al.  The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib. , 2009, Biochimica et biophysica acta.

[168]  H. Freeze Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients. , 2009, Biochimica et biophysica acta.

[169]  H. Freeze,et al.  Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG‐Ib) , 2000, Human mutation.

[170]  P. Möller,et al.  Abnormal surface expression of sialoglycans on B lymphocyte cell lines from patients with carbohydrate deficient glycoprotein syndrome I A (CDGS I A). , 1998, Glycobiology.

[171]  H. Freeze,et al.  Expanding spectrum of congenital disorder of glycosylation Ig (CDG‐Ig): Sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethality , 2007, American journal of medical genetics. Part A.

[172]  M. Harbison,et al.  Multiple serum protein abnormalities in carbohydrate-deficient glycoprotein syndrome: pathognomonic finding of two-dimensional electrophoresis? , 1992, Clinical chemistry.

[173]  Thierry Hennet,et al.  Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol‐linked oligosaccharides , 2009, Human mutation.

[174]  G. Dacremont,et al.  A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. , 2000, American journal of human genetics.

[175]  A. Munnich,et al.  Congenital disorders of glycosylation IIa cause growth retardation, mental retardation, and facial dysmorphism , 2000, Journal of medical genetics.

[176]  J. Jaeken Congenital disorders of glycosylation (CDG): it’s (nearly) all in it! , 2011, Journal of Inherited Metabolic Disease.

[177]  A. Torvik,et al.  Postmortem Findings in Two Patients with the Carbohydrate‐deficient Glycoprotein Syndrome , 1991 .

[178]  G. Matthijs,et al.  Effect of mutations found in carbohydrate‐deficient glycoprotein syndrome type IA on the activity of phosphomannomutase 2 , 1999, FEBS letters.

[179]  H. Schachter,et al.  The 'yellow brick road' to branched complex N-glycans. , 1991, Glycobiology.

[180]  M. Huizing,et al.  Hereditary inclusion body myopathy: a decade of progress. , 2009, Biochimica et biophysica acta.

[181]  J. Cruysberg,et al.  Ophthalmological abnormalities in children with congenital disorders of glycosylation type I , 2008, British Journal of Ophthalmology.

[182]  Y. Wada,et al.  Aberrant expressions of decorin and biglycan genes in the carbohydrate-deficient glycoprotein syndrome. , 1995, Journal of biochemistry.

[183]  H. Freeze,et al.  Enzymatic assay of D-mannose in serum. , 1997, Clinical chemistry.

[184]  H. Stroink,et al.  Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N‐glycan synthesis , 2000, Annals of neurology.

[185]  D. Vestweber,et al.  Discontinuation of fucose therapy in LADII causes rapid loss of selectin ligands and rise of leukocyte counts. , 2001, Blood.

[186]  E. Sprecher Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification. , 2010, The Journal of investigative dermatology.

[187]  E. Schaftingen,et al.  Phosphomannomutase deficiency is a cause of carbohydrate‐deficient glycoprotein syndrome type I , 1995, FEBS letters.

[188]  A. Karadimitris,et al.  Inherited glycosylphosphatidyl inositol deficiency: a treatable CDG. , 2009, Biochimica et biophysica acta.

[189]  R. Dwek,et al.  Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase , 2004, Nature Genetics.

[190]  H. Ropers,et al.  A defect in the TUSC3 gene is associated with autosomal recessive mental retardation. , 2008, American journal of human genetics.

[191]  S. Grünewald,et al.  The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). , 2009, Biochimica et biophysica acta.

[192]  S. Grünewald Congenital disorders of glycosylation: rapidly enlarging group of (neuro)metabolic disorders. , 2007, Early human development.

[193]  J. Jaeken,et al.  A Unique Pattern of Coagulation Abnormalities in Carbohydrate-Deficient Glycoprotein Syndrome , 1993, Pediatric Research.

[194]  P. Orlean Congenital disorders of glycosylation caused by defects in mannose addition during N-linked oligosaccharide assembly. , 2000, The Journal of clinical investigation.

[195]  C. Garel,et al.  Carbohydrate-deficient glycoprotein syndrome type I: a new cause of dysostosis multiplex , 1998, Skeletal Radiology.

[196]  D. Frommhold,et al.  Golgi GDP-fucose Transporter-deficient Mice Mimic Congenital Disorder of Glycosylation IIc/Leukocyte Adhesion Deficiency II* , 2007, Journal of Biological Chemistry.

[197]  P. Clayton,et al.  Prenatal diagnosis of the carbohydrate‐deficient glycoprotein syndrome type 1A (CDG1A) by a combination of enzymology and genetic linkage analysis after amniocentesis or chorionic villus sampling , 1998, Prenatal diagnosis.

[198]  H. Omran,et al.  Novel ALG8 mutations expand the clinical spectrum of congenital disorder of glycosylation type Ih. , 2009, Molecular genetics and metabolism.

[199]  H. Freeze,et al.  Direct utilization of mannose for mammalian glycoprotein biosynthesis. , 1998, Glycobiology.

[200]  K. von Figura,et al.  A New Type of Carbohydrate-deficient Glycoprotein Syndrome Due to a Decreased Import of GDP-fucose into the Golgi* , 1999, The Journal of Biological Chemistry.

[201]  F. Eyskens,et al.  Carbohydrate‐deficient glycoprotein syndrome with previously unreported features , 1994, Acta paediatrica.

[202]  N. Doggett,et al.  Comparative analysis of the phosphomannomutase genes PMM1, PMM2 and PMM2psi: the sequence variation in the processed pseudogene is a reflection of the mutations found in the functional gene. , 1998, Human molecular genetics.

[203]  R. Hubbard,et al.  The X-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 Å resolution , 1996, Nature Structural Biology.

[204]  R. Houlston,et al.  Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency , 2006, Nature Medicine.

[205]  E. Schaftingen,et al.  Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency). , 1999, Biochimica et biophysica acta.

[206]  U. Stephani,et al.  Carbohydrate-Deficient Glycoprotein Syndrome - A Fourth Subtype , 1995, Neuropediatrics.

[207]  L. Tsui,et al.  A novel missense mutation in the galactosyltransferase‐I (B4GALT7) gene in a family exhibiting facioskeletal anomalies and Ehlers–Danlos syndrome resembling the progeroid type , 2004, American journal of medical genetics. Part A.

[208]  G. Matthijs,et al.  Carbohydrate deficient glycoprotein (CDG) syndrome type I. , 1997, Journal of medical genetics.

[209]  R. Wevers,et al.  Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. , 2003, Clinical chemistry.

[210]  J. Jaeken,et al.  Endocrinology of the Carbohydrate-Deficient Glycoprotein Syndrome Type 1 from Birth through Adolescence , 1995, Pediatric Research.

[211]  L. Tengborn,et al.  Complex functional and structural coagulation abnormalities in the carbohydrate‐deficient glycoprotein syndrome type I , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[212]  Michael Y. Galperin,et al.  The catalytic domain of the P-type ATPase has the haloacid dehalogenase fold. , 1998, Trends in biochemical sciences.

[213]  R. Hennekam,et al.  Peters Plus Syndrome Is a New Congenital Disorder of Glycosylation and Involves Defective O-Glycosylation of Thrombospondin Type 1 Repeats* , 2008, Journal of Biological Chemistry.